Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5O2A

FolD Q98H

Summary for 5O2A
Entry DOI10.2210/pdb5o2a/pdb
DescriptorBifunctional protein FolD, ... (5 entities in total)
Functional Keywordscarolacton, fold, natural product, inhibitor, oxidoreductase
Biological sourceEscherichia coli (strain K12)
More
Total number of polymer chains4
Total formula weight124718.20
Authors
Koehnke, J.,Sikandar, A. (deposition date: 2017-05-19, release date: 2018-02-28, Last modification date: 2024-01-17)
Primary citationFu, C.,Sikandar, A.,Donner, J.,Zaburannyi, N.,Herrmann, J.,Reck, M.,Wagner-Dobler, I.,Koehnke, J.,Muller, R.
The natural product carolacton inhibits folate-dependent C1 metabolism by targeting FolD/MTHFD.
Nat Commun, 8:1529-1529, 2017
Cited by
PubMed Abstract: The natural product carolacton is a macrolide keto-carboxylic acid produced by the myxobacterium Sorangium cellulosum, and was originally described as an antibacterial compound. Here we show that carolacton targets FolD, a key enzyme from the folate-dependent C1 metabolism. We characterize the interaction between bacterial FolD and carolacton biophysically, structurally and biochemically. Carolacton binds FolD with nanomolar affinity, and the crystal structure of the FolD-carolacton complex reveals the mode of binding. We show that the human FolD orthologs, MTHFD1 and MTHFD2, are also inhibited in the low nM range, and that micromolar concentrations of carolacton inhibit the growth of cancer cell lines. As mitochondrial MTHFD2 is known to be upregulated in cancer cells, it may be possible to use carolacton as an inhibitor tool compound to assess MTHFD2 as an anti-cancer target.
PubMed: 29142318
DOI: 10.1038/s41467-017-01671-5
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

227111

數據於2024-11-06公開中

PDB statisticsPDBj update infoContact PDBjnumon